Last reviewed · How we verify

NCT06952738

Investigating Periprosthetic Fracture Cultures in Arthroplasty

Recruiting now Last updated 22 December 2025
What this trial tests

trial testing Not applicable- observational study in Periprosthetic Fracture Around Prosthetic Joint Implant in 200 participants. Currently enrolling.

Timeline
1 October 2025
Primary endpoint
30 April 2027
31 October 2027

Quick facts

Lead sponsorUniversity of Chicago
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment200
Start date1 October 2025
Primary completion30 April 2027
Estimated completion31 October 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Chicago

Who can join

18 and older, any sex, with Periprosthetic Fracture Around Prosthetic Joint Implant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to improve how doctors diagnose infections in patients with broken bones around joint replacements. Currently, there are no clear guidelines to help determine when an infection is present, making treatment decisions difficult. By studying how often infections are found through lab tests and identifying factors that predict infection, the investigators hope to create better ways to diagnose and care for these patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Not applicable- observational study

Trials testing the same drug.

Other recruiting trials for Periprosthetic Fracture Around Prosthetic Joint Implant

Currently open trials in the same condition.

Other University of Chicago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06952738.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing